We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Regulatory Protein Modulates Transmembrane Signals

By Biotechdaily staff writers
Posted on 08 Jul 2002
A regulatory protein called NHERF2 (sodium/hydrogen exchanger regulatory factor 2), a member of the PDZ class of proteins, has been shown to mediate the cell's response to binding of parathyroid hormone (PTH) and parathyroid hormone-related protein (PTHrP). More...
The study was reported in the June 20, 2002, issue of Nature.

PDZ domains were first identified as regions of sequence homology found in diverse signaling proteins. The name PDZ derives from the first three proteins in which these domains were identified: PSD-95 (a 95 kDa protein involved in signaling at the postsynaptic density), DLG (the Drosophila melanogaster Discs Large protein), and ZO-1 (the zonula occludens 1 protein involved in maintenance of epithelial polarity). PDZ domains function as protein-protein interaction modules. The first identified (and by far the most common) function of PDZ domains is the recognition of specific C-terminal motifs found in partner proteins, most often in the cytoplasmic tails of transmembrane receptors and channels.

Adenylyl cyclase activation is thought to be responsible for most cellular responses to PTH and PTHrP, although many actions appear to be independent of adenylyl cyclase. In the current study, researchers from Johns Hopkins University (Baltimore, MD, USA) and Harvard University (Boston, MA, USA) found that when NHERF2 is present along with the parathyroid hormone receptor, the signal is sent via calcium. If there is no NHERF2, then cAMP is responsible for delivering the message.

"The cell's decision to use calcium or cAMP is important because each generates different responses from its target proteins,” explained Dr. Mark Donowitz, professor of medicine at Johns Hopkins University and co-author of the study. "These results show that at the very earliest stage of cell signaling, called receptor binding, there is a switch that determines what kind of signal will be used. To understand cell signaling, you really have to know the whole system.”




Related Links:
Johns Hopkins University
Harvard University

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Prefilled Tubes
Prefilled 5.0ml Tubes
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study results show blood protein levels change markedly in childhood and adolescence, with sex differences increasing with age (photo credit: Adobe Stock)

Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

Serum proteins underpin many routine tests used to detect inflammation, hormonal imbalance, cardiovascular disease, and metabolic disorders. Yet pediatric interpretation often relies on adult reference... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.